Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 2
2008 2
2009 1
2010 1
2012 2
2013 1
2020 1
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Neutrophil-to-lymphocyte ratio (NLR) predicts mortality in hospitalized geriatric patients independent of the admission diagnosis: a multicenter prospective cohort study.
Di Rosa M, Sabbatinelli J, Soraci L, Corsonello A, Bonfigli AR, Cherubini A, Sarzani R, Antonicelli R, Pelliccioni G, Galeazzi R, Marchegiani F, Iuorio S, Colombo D, Burattini M, Lattanzio F, Olivieri F. Di Rosa M, et al. Among authors: burattini m. J Transl Med. 2023 Nov 21;21(1):835. doi: 10.1186/s12967-023-04717-z. J Transl Med. 2023. PMID: 37990223 Free PMC article.
Serum levels of soluble suppression of tumorigenicity 2 (sST2) and heart-type fatty acid binding protein (H-FABP) independently predict in-hospital mortality in geriatric patients with COVID-19.
Sabbatinelli J, Di Rosa M, Giuliani A, Domenichelli M, Bonfigli AR, Sarzani R, Cherubini A, Antonicelli R, Burattini M, Corsonello A, Galeazzi R, Babini L, Moretti M, Procopio AD, Lattanzio F, Olivieri F. Sabbatinelli J, et al. Among authors: burattini m. Mech Ageing Dev. 2023 Dec;216:111876. doi: 10.1016/j.mad.2023.111876. Epub 2023 Oct 4. Mech Ageing Dev. 2023. PMID: 37802485 Free article.
Improving the EHMRG Prognostic Evaluation of Acute Heart Failure with TAPSE/PASp: A Sequential Approach.
Falsetti L, Zaccone V, Viticchi G, Fioranelli A, Diblasi I, Guerrieri E, Ferrini C, Scarponi M, Giuliani L, Scalpelli C, Martino M, Pansoni A, Luccarini M, Burattini M, Moroncini G, Tarquinio N. Falsetti L, et al. Among authors: burattini m. Diagnostics (Basel). 2022 Feb 13;12(2):478. doi: 10.3390/diagnostics12020478. Diagnostics (Basel). 2022. PMID: 35204569 Free PMC article.
Implementation of EHMRG Risk Model in an Italian Population of Elderly Patients with Acute Heart Failure.
Falsetti L, Zaccone V, Guerrieri E, Perrotta G, Diblasi I, Giuliani L, Palma LEG, Viticchi G, Fioranelli A, Moroncini G, Pansoni A, Luccarini M, Martino M, Scalpelli C, Burattini M, Tarquinio N. Falsetti L, et al. Among authors: burattini m. J Clin Med. 2022 May 25;11(11):2982. doi: 10.3390/jcm11112982. J Clin Med. 2022. PMID: 35683368 Free PMC article.
Clusters of Comorbidities in the Short-Term Prognosis of Acute Heart Failure among Elderly Patients: A Retrospective Cohort Study.
Falsetti L, Viticchi G, Zaccone V, Guerrieri E, Diblasi I, Giuliani L, Giovenali L, Gialluca Palma LE, Marconi L, Mariottini M, Fioranelli A, Moroncini G, Pansoni A, Burattini M, Tarquinio N. Falsetti L, et al. Among authors: burattini m. Medicina (Kaunas). 2022 Oct 5;58(10):1394. doi: 10.3390/medicina58101394. Medicina (Kaunas). 2022. PMID: 36295555 Free PMC article.
Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Offidani M, Corvatta L, Polloni C, Piersantelli MN, Gentili S, Galieni P, Visani G, Alesiani F, Catarini M, Brunori M, Samori A, Burattini M, Centurioni R, Ferranti M, Giuliodori L, Candela M, Mele A, Marconi M, Leoni P. Offidani M, et al. Among authors: burattini m. Br J Haematol. 2009 Mar;144(5):653-9. doi: 10.1111/j.1365-2141.2008.07495.x. Epub 2008 Nov 13. Br J Haematol. 2009. PMID: 19036082 Free article. Clinical Trial.
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma.
Offidani M, Corvatta L, Piersantelli MN, Visani G, Alesiani F, Brunori M, Galieni P, Catarini M, Burattini M, Centurioni R, Ferranti M, Rupoli S, Scortechini AR, Giuliodori L, Candela M, Capelli D, Montanari M, Olivieri A, Poloni A, Polloni C, Marconi M, Leoni P. Offidani M, et al. Among authors: burattini m. Blood. 2006 Oct 1;108(7):2159-64. doi: 10.1182/blood-2006-03-013086. Epub 2006 Jun 8. Blood. 2006. PMID: 16763209 Free article. Clinical Trial.
ThaDD plus high dose therapy and autologous stem cell transplantation does not appear superior to ThaDD plus maintenance in elderly patients with de novo multiple myeloma.
Offidani M, Leoni P, Corvatta L, Polloni C, Gentili S, Savini A, Alesiani F, Brunori M, Catarini M, Visani G, Samori A, Burattini M, Centurioni R, Montanari M, Fraticelli P, Ruggieri M, Falcioni S, Galieni P. Offidani M, et al. Among authors: burattini m. Eur J Haematol. 2010 Jun;84(6):474-83. doi: 10.1111/j.1600-0609.2010.01418.x. Epub 2010 Mar 11. Eur J Haematol. 2010. PMID: 20331733 Clinical Trial.
14 results